scholarly article | Q13442814 |
P2093 | author name string | Kadlubar FF | |
Shin S | |||
Yokoi T | |||
Nakajima M | |||
Kamataki T | |||
Mizutani M | |||
P433 | issue | 5 | |
P921 | main subject | phenotype | Q104053 |
P304 | page(s) | 413-421 | |
P577 | publication date | 1994-07-01 | |
P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
P1476 | title | Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene | |
P478 | volume | 3 |
Q33322926 | Biomonitoring of complex occupational exposures to carcinogens: the case of sewage workers in Paris |
Q36063995 | Caffeine Cytochrome P450 1A2 Metabolic Phenotype Does Not Predict the Metabolism of Heterocyclic Aromatic Amines in Humans |
Q56795476 | Caffeine N3-demethylation (CYP1A2) in a population with an increased exposure to polychlorinated biphenyls |
Q37001556 | Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers |
Q24806052 | Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study |
Q55043253 | Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population. |
Q47771449 | Determination of -3858G-->A and -164C-->A genetic polymorphisms of CYP1A2 in blood and saliva by rapid allelic discrimination: large difference in the prevalence of the -3858G-->A mutation between Caucasians and Asians |
Q35039136 | Differential pharmacokinetics of theophylline in elderly patients |
Q33700123 | Drug interactions with tobacco smoking. An update |
Q58615950 | Effects of Common CYP1A2 Genotypes and other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: an Exploratory Analysis |
Q35036312 | Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia. |
Q41593416 | Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine |
Q37286958 | Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer |
Q41908761 | Genetic polymorphisms of cytochrome P450-1A2 (CYP1A2) among Emiratis |
Q36807462 | Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population |
Q39042845 | Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population |
Q41172369 | Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism |
Q46359082 | Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 -163C>A polymorphism |
Q41073233 | Molecular basis of polymorphic drug metabolism |
Q30886181 | Nonparametric expectation maximisation (NPEM) population pharmacokinetic analysis of caffeine disposition from sparse data in adult caucasians: systemic caffeine clearance as a biomarker for cytochrome P450 1A2 activity |
Q24811520 | PCB exposure and in vivo CYP1A2 activity among Native Americans |
Q34534425 | Pharmacogenetics of asthma |
Q46872878 | Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy |
Q36055051 | Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population |
Q48577324 | Phenotyping of CYP 4501A2 Activity by Total Overnight Salivary Caffeine Assessment (TOSCA) in Patients on Warfarin Treatment: A Cross-Sectional Study. |
Q42284296 | Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. |
Q34834089 | Racial, ethnic, and gender variations in cancer risk: considerations for future epidemiologic research |
Q36053773 | Tacrine is not an ideal probe drug for measuring CYP1A2 activity in vivo |
Q36055087 | The effect of NAT2 genotype and gender on the metabolism of caffeine in nonsmoking subjects. |
Search more.